Understanding T-cell Response in Colorectal Cancer
Interdisciplinary Epidemiologic Consortium to Investigate T-cell Response in Colorectal Cancer
['FUNDING_R01'] · FRED HUTCHINSON CANCER CENTER · NIH-11066501
This project explores how the body's immune cells, called T-cells, respond to colorectal cancer and what factors influence this response.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FRED HUTCHINSON CANCER CENTER (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11066501 on ClinicalTrials.gov |
What this research studies
Our immune system plays a big role in how cancers grow and progress, especially in colorectal cancer. We know that a strong T-cell response often leads to better outcomes for patients. This project aims to discover what personal factors, like genetics and lifestyle choices, and what tumor characteristics, such as specific bacteria or gene changes, are connected to this important T-cell response. By understanding these connections, we hope to find new ways to improve treatments for colorectal cancer.
Who could benefit from this research
Good fit: This research focuses on understanding factors in patients with colorectal cancer.
Not a fit: Patients without colorectal cancer would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to predict how patients with colorectal cancer will respond to treatment and help develop more effective immunotherapies.
How similar studies have performed: While the importance of T-cell response in cancer is known, this project aims to uncover new specific genetic, lifestyle, and tumor factors influencing it, making its approach novel in its comprehensive scope.
Where this research is happening
SEATTLE, UNITED STATES
- FRED HUTCHINSON CANCER CENTER — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PETERS, ULRIKE — FRED HUTCHINSON CANCER CENTER
- Study coordinator: PETERS, ULRIKE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.